Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
In addition to Steitz, Moore and Jorgensen, the scientific founders of Rib-X include Dr. Harry Noller, from the University of California, Santa Cruz and Dr. John Abelson, from the California Institute of Technology. Noller has spent his entire career pursuing studies of the ribosome. He brings to the Rib-X founding team an in-depth understanding of the genetics and biochemistry of ribosome function. Dr. Abelson was a founding scientist at Agouron, and as such brings to Rib-X his experience in guiding structure-based drug discovery programs into the clinic. Since many of the antibiotics that bind to the ribosome interact specifically with RNA, Abelson’s scientific expertise in the area of RNA biochemistry contributes a further valuable component to the elite founding team. ( www.rib-x.com )
Rib-X Pharmaceuticals , Inc.
300 George Street Suite 301
New Haven, Connecticut 06511
USA
Tel: (203) 624-5606
Fax: (203) 624-5627